IXJ ETF Analysis: Global Healthcare | NYSE
Healthcare Equity | NYSE, USA | Market Cap: 4.636m USD | 12M Return: 25.6% | US4642873255 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 31.0M
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The iShares Global Healthcare ETF (IXJ) is designed to track the S&P Global 1200 Health Care (Sector) Capped Index, providing investors with exposure to large-cap healthcare companies across major global markets. The underlying index is a subset of the broader S&P Global 1200 and is maintained by S&P Dow Jones Indices LLC, a subsidiary of S&P Global. By focusing on the healthcare sector, the fund targets companies involved in areas such as pharmaceuticals, biotechnology, medical devices, and healthcare services, sectors typically characterized by relatively stable demand driven by demographic trends and ongoing medical innovation.
- Drug pricing regulation pressures pharmaceutical margins
- Aging demographics in developed markets boost healthcare demand
- US dollar strength compresses international healthcare holdings
As of November 11, 2026, the stock is trading at USD 114.97 with a total of 118,765 shares traded. Over the past week, the price has changed by +2.69%, over one month by +10.84%, over three months by +11.07% and over the past year by +25.59%.
Current recommended Stop Loss: 112.50 (which is 2.1% or 1.2 ATR below the current price).
Global Healthcare has no consensus analysts rating.